Syrona Women company
%20.jpg)
Syrona Women develops a non-invasive cancer screening kit designed to facilitate early stage detection of gynecological cancers at home. The company's kit combines an automated diagnostic technology and a unique sample that enables detection of multiple novel biomarkers indicative of STIs and reproductive cancers, STDs and gynecological cancers so as to let women screen and manage their own reproductive health at homes, enabling women to keep a check of their gynecological health by themselves without having to wait for time-consuming diagnostics in clinics.
Funding Status:
Seed
Industry:
Health Care
Estimated Revenue:
Less than $1M
Technology:
Longevity FemTech
Headquarters:
London, England, United Kingdom
Total Funding:
$678.9K
Last Funding Type:
Grant
Investor Type:
For Profit
Employee Number:
1-10
Investors Number:
2
Founded Date:
2018-01-01